chrX-53201956-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_004187.5(KDM5C):c.1764G>A(p.Gln588Gln) variant causes a synonymous change. The variant allele was found at a frequency of 0.00356 in 1,210,364 control chromosomes in the GnomAD database, including 10 homozygotes. There are 1,364 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0029 ( 1 hom., 84 hem., cov: 23)
Exomes 𝑓: 0.0036 ( 9 hom. 1280 hem. )
Consequence
KDM5C
NM_004187.5 synonymous
NM_004187.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.17
Genes affected
KDM5C (HGNC:11114): (lysine demethylase 5C) This gene is a member of the SMCY homolog family and encodes a protein with one ARID domain, one JmjC domain, one JmjN domain and two PHD-type zinc fingers. The DNA-binding motifs suggest this protein is involved in the regulation of transcription and chromatin remodeling. Mutations in this gene have been associated with X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant X-53201956-C-T is Benign according to our data. Variant chrX-53201956-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 166871.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-53201956-C-T is described in Lovd as [Benign]. Variant chrX-53201956-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00287 (322/112344) while in subpopulation NFE AF= 0.0049 (261/53263). AF 95% confidence interval is 0.00441. There are 1 homozygotes in gnomad4. There are 84 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 84 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM5C | NM_004187.5 | c.1764G>A | p.Gln588Gln | synonymous_variant | 13/26 | ENST00000375401.8 | NP_004178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM5C | ENST00000375401.8 | c.1764G>A | p.Gln588Gln | synonymous_variant | 13/26 | 1 | NM_004187.5 | ENSP00000364550.4 |
Frequencies
GnomAD3 genomes AF: 0.00287 AC: 322AN: 112291Hom.: 1 Cov.: 23 AF XY: 0.00244 AC XY: 84AN XY: 34433
GnomAD3 genomes
AF:
AC:
322
AN:
112291
Hom.:
Cov.:
23
AF XY:
AC XY:
84
AN XY:
34433
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00266 AC: 489AN: 183506Hom.: 0 AF XY: 0.00290 AC XY: 197AN XY: 67936
GnomAD3 exomes
AF:
AC:
489
AN:
183506
Hom.:
AF XY:
AC XY:
197
AN XY:
67936
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00363 AC: 3989AN: 1098020Hom.: 9 Cov.: 30 AF XY: 0.00352 AC XY: 1280AN XY: 363378
GnomAD4 exome
AF:
AC:
3989
AN:
1098020
Hom.:
Cov.:
30
AF XY:
AC XY:
1280
AN XY:
363378
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00287 AC: 322AN: 112344Hom.: 1 Cov.: 23 AF XY: 0.00244 AC XY: 84AN XY: 34496
GnomAD4 genome
AF:
AC:
322
AN:
112344
Hom.:
Cov.:
23
AF XY:
AC XY:
84
AN XY:
34496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 24, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 04, 2016 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 14, 2019 | This variant is associated with the following publications: (PMID: 19377476, 24583395) - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
KDM5C-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at